Showing results (2251-2260 of 3,888) with videos related to
Sort By:
Pageof 389
Cancer Biology & Therapy|October 30, 2016
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapseValerio Nardone, Cirino Botta, Michele Caraglia, et al.Cancer Biology & Therapy|October 30, 2016
Belinostat and vincristine demonstrate mutually synergistic cytotoxicity associated with mitotic arrest and inhibition of polyploidy in a preclinical model of aggressive diffuse large B cell lymphomaAaron P Havas, Kameron B Rodrigues, Anvi Bhakta, et al.Cancer Biology & Therapy|February 21, 2008
Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: the mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1Xin-zhi Huang, Jie Wang, Chao Huang, et al.Cancer Biology & Therapy|February 21, 2008
Validation and toxicity of PI3K/Akt pathway inhibition by HIV protease inhibitors in humansJohn P Plastaras, Neha Vapiwala, Mona S Ahmed, et al.Cancer Biology & Therapy|February 26, 2008
A new rat model of human breast cancer for evaluating efficacy of new anti-cancer agents in vivoWieteke G E Direcks, Marcelle van Gelder, Adriaan A Lammertsma, et al.Cancer Biology & Therapy|February 26, 2008
Proteasome inhibitor MG132 reverses multidrug resistance of gastric cancer through enhancing apoptosis and inhibiting P-gpYafei Zhang, Yongquan Shi, Xiaohua Li, et al.Cancer Biology & Therapy|February 5, 2008
Identification of candidate biomarkers for hepatocellular carcinoma through pre-cancerous expression analysis in an HBx transgenic mouseQiang Sun, Yingai Zhang, Fang Liu, et al.Cancer Biology & Therapy|February 19, 2008
The oncolytic adenovirus targeting to TERT and RB pathway induced specific and potent anti-tumor efficacy in vitro and in vivo for hepatocellular carcinomaWei Zhang, Rong Cai, Jingjing Luo, et al.Cancer Biology & Therapy|February 6, 2014
Targeting the unfolded protein response, XBP1, and the NLRP3 inflammasome in fibrosis and cancerBeth Overley-Adamson, Carol M Artlett, Connie Stephens, et al.Cancer Biology & Therapy|February 6, 2014
Not so WEE: targeting G₂/M to kill mesothelioma cellsPaul DentPageof 389